CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Employees - 300000,
CEO - J. David Joyner,
Sector - Healthcare,
Country - US,
Market Cap -
Altman ZScore(max is 10): 2.44, Piotroski Score(max is 10): 7, Working Capital: $-11589000000, Total Assets: $252974000000, Retained Earnings: $63282000000, EBIT: 6565000000, Total Liabilities: $175337000000, Revenue: $407905000000
AryaFin Target Price - $248.2 - Current Price $ - Analyst Target Price $
| Ticker | CVS |
| Index | |
| Curent Price | |
| Change | |
| Market Cap | |
| Average Volume | |
| Income | |
| Sales | |
| Book Value/Share | |
| Cash/Share | |
| Dividend Est | |
| Dividend TTM | |
| Dividend Ex-Date | |
| Employees | |
| Moving Avg 20days | |
| Moving Avg 50days | |
| Moving Avg 200days | |
| Shares Outstanding | |
| Earnings Date | |
| Inst. Ownership |
| Price/Earnings | |
| Forwad P/E | |
| PE Growth | |
| Price/Sales | |
| Price/Book | |
| Price/Cash | |
| Price/FCF | |
| Quick Ratio | |
| Current Ratio | |
| Debt/Equity | |
| Return on Assets | |
| Return on Equity | |
| Return on Investment | |
| Gross Margin | |
| Ops Margin | |
| Profit Margin | |
| RSI | |
| BETA(β) | |
| From 52week Low | |
| From 52week High |
| EPS | |
| EPS next Year | |
| EPS next Qtr | |
| EPS this Year | |
| EPS next 5 Year | |
| EPS past 5 Year | |
| Sales past 5 Year | |
| EPS Y/Y | |
| Sales Y/Y | |
| EPS Q/Q | |
| Sales Q/Q | |
| Sales Surprise | |
| EPS Surprise | |
| ATR(14) | |
| Perf Week | |
| Perf Month | |
| Perf Quarter | |
| Perf Year | |
| Perf YTD | |
| Target Price |
AryaFin Engine© - An AI FinTech Venture - 2024-26 Disclaimer